Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm receives $2.32m R&D tax incentive refund

Nov 15, 2018 at 2:50 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment